Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MGNX Macrogenics Inc	$77.4M	$0 0.0% of portfolio	0	Q4 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.61B	$0 0.0% of portfolio	1	Q4 2023 New
MAIA Maia Biotechnology, Inc.	$17.7M	$0 0.0% of portfolio	0	Q4 2024 New
MNKD Mannkind Corp	$1.29B	$0 0.0% of portfolio	74	Q1 2022 New
MRVI Maravai Lifesciences Holdings, Inc.	$310M	$0 0.0% of portfolio	0	Q4 2024 New
MRKR Marker Therapeutics, Inc.	$106M	$0 0.0% of portfolio	0	Q4 2024 New
MNOV Medicinova Inc	$72.6M	$0 0.0% of portfolio	0	Q4 2024 New
MGTX Meira G Tx Holdings PLC	$330M	$0 0.0% of portfolio	0	Q4 2024 New
MREO Mereo Biopharma Group PLC	$297M	$0 0.0% of portfolio	0	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$36.9M	$0 0.0% of portfolio	0	Q4 2024 New
MRUS Merus N.V.	$2.05B	$0 0.0% of portfolio	0	Q4 2024 New
MTCR Metacrine, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
MIST Milestone Pharmaceuticals Inc.	$26.4M	$0 0.0% of portfolio	0	Q4 2024 New
MDXG Mimedx Group, Inc.	$857M	$0 0.0% of portfolio	0	Q4 2024 New
NERV Minerva Neurosciences, Inc.	$9.61M	$0 0.0% of portfolio	0	Q4 2024 New
INKT Mi Nk Therapeutics, Inc.	$305M	$0 0.0% of portfolio	0	Q4 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.69B	$0 0.0% of portfolio	0	Q4 2024 New
MOLN Molecular Partners Ag	$148M	$0 0.0% of portfolio	0	Q4 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$238M	$0 0.0% of portfolio	0	Q4 2024 New
MLTX Moon Lake Immunotherapeutics	$1.47B	$0 0.0% of portfolio	0	Q4 2024 New
MYOV Myovant Sciences Ltd.	$0	$0 0.0% of portfolio	0	Q4 2024 New
NBTX Nanobiotix S.A.	$125M	$0 0.0% of portfolio	0	Q4 2024 New
NAUT Nautilus Biotechnology, Inc.	$111M	$0 0.0% of portfolio	0	Q4 2024 New
NKTR Nektar Therapeutics	$139M	$0 0.0% of portfolio	0	Q4 2024 New
NRSN Neuro Sense Therapeutics Ltd.	$11.7M	$0 0.0% of portfolio	0	Q4 2024 New
NXTC Next Cure, Inc.	$14.2M	$0 0.0% of portfolio	0	Q4 2024 New
NKTX Nkarta, Inc.	$97.3M	$0 0.0% of portfolio	0	Q4 2024 New
NVAX Novavax Inc	$548M	$0 0.0% of portfolio	1	Q4 2024 New
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$0 0.0% of portfolio	0	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$573M	$0 0.0% of portfolio	0	Q4 2024 New
NTRB Nutri Band Inc.	$48.8M	$0 0.0% of portfolio	0	Q4 2024 New
NUVL Nuvalent, Inc.	$3.14B	$0 0.0% of portfolio	0	Q4 2024 New
NUVB Nuvation Bio Inc.	$395M	$0 0.0% of portfolio	0	Q4 2024 New
NVCT Nuvectis Pharma, Inc.	$153M	$0 0.0% of portfolio	0	Q4 2024 New
OBSV Obs Eva Sa	$0	$0 0.0% of portfolio	0	Q4 2024 New
OCGN Ocugen, Inc.	$173M	$0 0.0% of portfolio	0	Q4 2024 New
OCUL Ocular Therapeutix, Inc	$583M	$0 0.0% of portfolio	0	Q4 2024 New
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	0	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$171M	$0 0.0% of portfolio	0	Q4 2024 New
OMGA Omega Therapeutics, Inc.	$957K	$0 0.0% of portfolio	0	Q4 2024 New
OMER Omeros Corp	$531M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.